Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?

Narod SA, Metcalfe K, Lynch HT, Ghadirian P, Robidoux A, Tung N, Gaughan E, Kim-Sing C, Olopade OI, Foulkes WD, Robson M, Offit K, Jakubowska A, Byrski T, Huzarski T, Sun P, Lubinski J.

Breast Cancer Res Treat. 2013 Feb;138(1):273-9. doi: 10.1007/s10549-013-2429-x. Epub 2013 Feb 6.

PMID:
23381743
2.

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.

Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A.

Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Review.

PMID:
20033769
3.

Tumor size and survival in breast cancer--a reappraisal.

Foulkes WD, Reis-Filho JS, Narod SA.

Nat Rev Clin Oncol. 2010 Jun;7(6):348-53. doi: 10.1038/nrclinonc.2010.39. Epub 2010 Mar 23. Review.

PMID:
20309006

Supplemental Content

Support Center